SNAP2

  • Research type

    Research Study

  • Full title

    Randomised Controlled Trial of Self-management of Postnatal Antihypertensive Treatment

  • IRAS ID

    332333

  • Contact name

    Richard McManus

  • Contact email

    richard.mcmanus@phc.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Clinicaltrials.gov Identifier

    n/a, n/a

  • Duration of Study in the UK

    2 years, 8 months, 31 days

  • Research summary

    Raised blood pressure (BP) during and following pregnancy affects around 80,000 women each year in the UK, and can lead to very serious problems such as pre-eclampsia or stroke. After birth, a women’s BP can remain elevated, but in most cases returns to normal over 2–12 weeks. During this period, medication needs to be adjusted to achieve the correct control. Research suggests that better BP control during this period is associated with improved long-term health outcomes. This trial aims to test whether a self-management approach can improve BP control in women with medicated hypertensive disorders in the postnatal period. The self-management approach will include self-monitoring and using a Smartphone app. Blood pressure readings will be looked at by their own health care professionals who will oversee any medication changes.

  • REC name

    South Central - Oxford B Research Ethics Committee

  • REC reference

    24/SC/0071

  • Date of REC Opinion

    9 May 2024

  • REC opinion

    Further Information Favourable Opinion